SALEM INVESTMENT COUNSELORS INC
Position in HIMS — Hims & Hers Health, Inc.
CIK 884423
WINSTON-SALEM, NC
Position in HIMS
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$13,868
-$7,411 QoQ
Shares Held
400
-61.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#420
of 504 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SALEM INVESTMENT COUNSELORS INC holds $1,287,735 across 14 Drug Manufacturers - Specialty & Generic names. HIMS ranks #7 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GLAS |
Glass House Brands Inc.
|
51,133 | $664,729 | |
| 2 | VTRS |
Viatris Inc
|
13,446 | $213,522 | |
| 3 | DERM |
Journey Medical Corp
|
29,200 | $206,736 | |
| 4 | HLN |
Haleon plc
|
9,114 | $85,033 | |
| 5 | HROW |
Harrow, Inc.
|
1,300 | $55,211 | |
| 6 | ZTS |
Zoetis Inc.
|
586 | $42,109 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
This page
|
400 | $13,868 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
200 | $2,000 |
All Filings in HIMS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,868 | 400 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $21,279 | 1,025 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $8,690,043 | 267,633 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $14,905,051 | 262,783 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $13,068,825 | 262,163 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $7,844,579 | 265,468 | Shares | Sole | 2025-04-16 | |
| No filing history on record for this holder in this stock. | ||||||